🧬 Doug Drysdale - Cybin - Part 1 | One Teacher Can Change Your Whole Perspective | The Forefront of the Human Genome Project | How Loss Taught Him Not to Take Life For Granted | Learning How to Be Personable in Sales

The Biotech Startups Podcast

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 1 of 4.

My guest for this week’s episode is Doug Drysdale, CEO at Cybin. Cybin is a clinical-stage biopharma company on a mission to create safe and effective psychedelic-based therapeutics. Their goal is to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Doug is an experienced investor, Corporate Director and CEO, who has chaired the Board of a NASDAQ-listed company and, as a CEO for the past 12 years, has built and turned around 3 pharma companies. During Doug’s 30+ years of experience in the healthcare sector, he has formed cohesive management teams, recruited board members, completed 16 corporate acquisitions across three continents and has raised and invested around $4 billion of both public and private capital.

Before Cybin, Doug was Commercial Products Manager at DuPont Merck, Director of BD at Elan, VP of M&A at Actavis Group, CEO of Norwich Pharmaceuticals and Alvogen, CEO of Pernix Therapeutics, and CEO of Tedor Pharma. Doug’s extensive background as a seasoned executive, investor, and turn-around specialist gives him a wide range of experiences that founders can learn from.

Join us this week and hear about:

• Doug’s upbringing in a working-class setting
• His life-changing scholarship and his early passion for the life sciences
• Doug’s pivotal moments in the lab and his transition to sales at DuPont Merck
• His time at Elan, where he combined his scientific and commercial expertise to excel in BD

Please enjoy my conversation with Doug Drysdale.

Timestamps:

00:28 Intro

02:33 Episode starts, Doug’s early upbringing and how a teacher helped change his life and perspective at only 10 years old

06:40 Doug finding his spark for science, his gravitation toward biology, working a government job in a hospital pathology lab out of high school

11:53 Getting a degree in molecular biology and being able to work with the cutting-edge human genome project

13:13 Transitioning out of government wet lab and into full-time study at University of East Anglia

15:38 Mentors and professors who inspired Doug’s journey in STEM, a family loss swaying Doug to get out of academia and go into sales

20:36 How an opportunity at DuPont Merck came about and the joint venture experience at this startup

23:04 Memorable challenges and triumphs in pharmaceutical sales

26:44 First-time experience as a commercial marketing manager, being recruited into Elan in a marketing role

30:10 Outro

Find Our Guest, Doug Drysdale, at these links:

https://www.linkedin.com/in/dougdrysdale/

https://cybin.com/

Find Our Host, Jon Chee, at these links:

https://www.linkedin.com/in/jonchee

https://www.excedr.com

Social & Website

LinkedIn: https://www.linkedin.com/company/excedr/

Youtube: https://www.youtube.com/@excedr

Instagram: https://www.instagram.com/excedr_inc

Twitter: https://twitter.com/ExcedrInc

Facebook: https://www.facebook.com/excedr

TikTok: https://www.tiktok.com/@excedr

Podcast Website: https://www.thebiotechstartupspodcast.com/

Enriched Notes:

Topics Mentioned:

Marketing & Sales Strategies for Startups https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs

How to Fund an R&D Startup: First Steps a Founder Can Take https://www.excedr.com/resources/rd-startup-funding-first-steps

Biotech Partnerships: How Partnering with Big Pharma Can Support R&D https://www.excedr.com/blog/how-biotech-partnerships-support-research

Guide to Life Sciences Licensing Agreements https://www.excedr.com/blog/life-sciences-licensing-agreements-guide

The Biotech Startups Podcast is handcrafted by our friends over at: fame.so